Abstract:OBJECTIVE To study the pharmacokinetics and bioequivalence of isosorbide 5-mononitrate and aspirin from compound isosorbide mononitrate sustained released tablets in healthy volunteers.METHODS Isosorbide mononitrate sustained release tablets and aspirin enteric-coated tablets were used as the reference preparations.In a randomized crossover design,single and multiple doses of test and reference preparations were given to 20 and 18 healthy male volunteers respectively. Isosorbide-5-mononitrate and salicylic acid concentrations were measured by ESI-MSD and DAD respectively. RESULTS After a single oral administration,the pharmacokinetic parameters of isosorbide 5-mononitrate test and control preparations were as following:AUC_~0→36 h (10 025.1±1 336.9) and (9 472.0±1 139.3)μg·h·L~-1 ;t_~max (4.7±1.0) and (4.5±0.8) h;c_~max (661.9±76.5) and (658.0±83.2) μg·L~-1 , respectively. For salicylic acid, the pharmacokinetic parameters were as AUC_~0→∞ (21 864±6 239) and (18 872±5 379) μg·h·L~-1 ;t_~max (0.8±0.4) and (4.7±1.0) h;c_~max (6 050±1 133) and (3 797±872)μg·L~-1 ,respectively. The relative bioavailability of isosorbide 5-mononitratte and salicylic acid were (105.9±6.4)% and (117.5±19.3)%,respectively. After multiple oral administration of test and reference preparations,the pharmacokinetic parameters were as following:AUC_~ss (10 333.5±1 519.2) and (10 410.5±1 767.5) μg·h·L~-1 ;t_~max (4.3±1.1) and (4.3±0.8) h;c_~max (724.8±95.5) and (786.7±110.0) μg·L~-1 ;c_~min (129.4±40.0) and (121.9±36.0) μg·L~-1 ;c_~av (430.6±63.3) and (433.8±73.6) μg·L~-1 ; DF (140.1±15.9)% and (155.2±20.7)%,respectively. The relative bioavailability of isosorbide 5-mononitrate was (100.5±13.0)%. CONCLUSION Compoud isosorbide mononitrate sustained release tablets showed bioequivalence for the isosorbide 5-mononitrate component with the reference preparation, and the AUC for the aspirin component was bioequivalent with that of the reference drug,but the test drug was more rapidly absorbed.

Study on Relative Bioavailability of Different Sinomenine Hydrochloride Crystal in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Relative bioavailability of disodium etidronate capsules in healthy volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Bioequivalence of Glipizide Controlled-Release Tablets in Chinese Healthy Volunteers

Study on Bioequivalence of Glucosamine Indometacin Enteric-coated Tablets in Healthy Volunteers

Bioequivalence of zopiclone tablet in Chinese healthy volunteers

Pharmacokinetics, Pharmacodynamics, and Bioequivalence Study of SciLin TMR Recombinant Human Insulin Injection Preparation

Study on the Pharmacokinetics and Bioequivalence of Isosorbide 5-Mononitrate and Aspirin from Compound Isosorbide Mononitrate Sustained Release Tablets in Healthy Volunteers

Portable Raman Spectroscopy and Fourier Transform Near Infrared Spectroscopy for the Quantification of Different Sinomenine Hydrochloride Crystal Forms

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

RELATIVE BIOAVAILABILITY OF DOMESTIC CONTROLLED RELEASE MORPHINE SULPHATE TABLET IN CHINESE VOLUNTEERS

Pharmacokinetics and bioequivalence study of escitalopram oxalate formulations after single-dose administration in healthy Chinese male volunteers

Pharmacokinetics and Bioequivalence Studies of Galantamine Hydrobromide Dispersible Tablet in Healthy Male Chinese Volunteers

Study of Relative Bioavailability of Aciclovir Tablet in Healthy Volunteers

Pharmacokinetics and bioequivalence of naproxen sodium sustained release tablets in healthy volunteers

Bioequivalence of Lansoprazole Enteric Caspsules in Healthy Volunteers

Relative bioavailability of acetaminophen nasal drops in human volunteers by reversed phase HPLC

Bioequivalence of glycyrrhizin capsules by HPLC-MS